What's in Universidade Estadual de Ponta Grossa's pipeline?

Universidade Estadual de Ponta Grossa has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Universidade Estadual de Ponta Grossa's portfolio?

Top competitors by shared drug class: AFT Pharmaceuticals, Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidade-estadual-de-ponta-grossa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Universidade Estadual de Ponta Grossa — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidade Estadual de Ponta Grossa pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
acetam/ketoro tromet group	acetam/ketoro tromet group	phase 3	Fixed-dose combination analgesic/NSAID		Pain Management

Therapeutic area mix

Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AFT Pharmaceuticals, Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidade Estadual de Ponta Grossa:

Cite this brief

Drug Landscape (2026). Universidade Estadual de Ponta Grossa — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidade-estadual-de-ponta-grossa. Accessed 2026-05-16.